PARIS (Reuters) – Shares in France’s Valneva reversed course on the Paris stock market and traded down by around 2.8% after the country’s public health authority said it would advise the government not to use the company’s COVID-19 vaccine for its vaccination strategy.
(Reporting by Tassilo Hummel; Editing by Sudip Kar-Gupta)
